Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kappos

Showing results (141-150 of 225) with videos related to

Pageof 23
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 22, 2022
Prognostic biomarkers in primary progressive multiple sclerosis: Validating and scrutinizing multimodal evoked potentialsM Hardmeier, R Schlaeger, A M Lascano, et al.
Neurology|February 25, 2011
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosisJ Kuhle, D Leppert, A Petzold, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 15, 2020
The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosisT Derfuss, J Sastre-Garriga, X Montalban, et al.
Neurology|November 28, 2001
Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of lifeJ A Freeman, A J Thompson, R Fitzpatrick, et al.
European Journal of Neurology|February 26, 2020
Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatmentV von Wyl, B F Décard, P Benkert, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1990
Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donorsM Pette, K Fujita, D Wilkinson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 17, 2011
Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessmentD J Rigotti, A Gass, L Achtnichts, et al.
Neuropathology and Applied Neurobiology|April 28, 2006
Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in childrenR L P Lindberg, T Sorsa, T Tervahartiala, et al.
Neurology|May 6, 2011
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosisP W O'Connor, A Goodman, L Kappos, et al.
European Journal of Neurology|December 21, 2012
Six-year follow-up of a case series with non-communicating syringomyelia in multiple sclerosisK Weier, Y Naegelin, M Amann, et al.
Pageof 23

Showing results (141-150 of 225) with videos related to

Sort By:
Pageof 23
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|March 22, 2022
Prognostic biomarkers in primary progressive multiple sclerosis: Validating and scrutinizing multimodal evoked potentialsM Hardmeier, R Schlaeger, A M Lascano, et al.
Neurology|February 25, 2011
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosisJ Kuhle, D Leppert, A Petzold, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 15, 2020
The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosisT Derfuss, J Sastre-Garriga, X Montalban, et al.
Neurology|November 28, 2001
Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of lifeJ A Freeman, A J Thompson, R Fitzpatrick, et al.
European Journal of Neurology|February 26, 2020
Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatmentV von Wyl, B F Décard, P Benkert, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1990
Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donorsM Pette, K Fujita, D Wilkinson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 17, 2011
Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessmentD J Rigotti, A Gass, L Achtnichts, et al.
Neuropathology and Applied Neurobiology|April 28, 2006
Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in childrenR L P Lindberg, T Sorsa, T Tervahartiala, et al.
Neurology|May 6, 2011
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosisP W O'Connor, A Goodman, L Kappos, et al.
European Journal of Neurology|December 21, 2012
Six-year follow-up of a case series with non-communicating syringomyelia in multiple sclerosisK Weier, Y Naegelin, M Amann, et al.
Pageof 23